Trial Profile
Phase II Trial of Flavopiridol and Cisplatin in Advanced Epithelial Ovarian and Primary Peritoneal Carcinomas
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Alvocidib (Primary) ; Cisplatin (Primary)
- Indications Ovarian cancer; Peritoneal cancer
- Focus Therapeutic Use
- 17 May 2011 Actual end date (Mar 2010) added as reported by ClinicalTrials.gov.
- 17 May 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 05 Apr 2011 Results presented at AACR 2011.